If you are a Sickle Cell Warrior or caregiver reviewing Medicare coverage, now is an important time to understand your options.
Medicare Open Enrollment runs from October 15–December 7, 2026.
During this period, Medicare recipients can review or change their Medicare health and prescription drug coverage. Any changes made during Open Enrollment take effect January 1, 2027.
Knowing these dates can help you plan ahead and take time to review your coverage before the enrollment period ends.
Save this post as a reminder, and share it with a Sickle Cell Warrior or caregiver who may find it helpful.
#SickleCellDisease #SickleCellWarrior #Medicare #HealthInsurance #CaregiverSupport #PatientEducation #FSCDR
12
📚 SCD Weekly Practice Update
A public health led, statewide approach to improving emergency department care for individuals with sickle cell disease — North Carolina
A statewide initiative described in the Journal of Sickle Cell Disease aims to improve emergency department care for individuals with sickle cell disease through clinical guidance, expert consultation, and coordinated support.
🔍 Study Highlights
Using 2013–2019 North Carolina hospital-discharge data, the initiative identified the 20 EDs with the highest SCD visit volumes. Implementation began with the top five EDs and expanded to the next five.
💡 Key findings included:
The report found that 9.4% of patients accounted for 58% of ED visits.
The initiative includes a clinical toolbox with existing recommendations, an ED order-set template, opioid calculator, weight-based dosing chart, individualized pain-plan resources, and quality-improvement tools.
The high-ED-use subgroup established consensus-based referral criteria of at least 10 annual ED visits for adults and four for children. These thresholds are not validated definitions.
Monthly expert-consultation calls and a multi-institutional patient-care conference support implementation and complex-case coordination.
The report does not demonstrate improved care or outcomes to date.
💡 Why It Matters
The initiative combines clinical guidance with practical implementation support and ongoing consultation across emergency departments.
Planned supports for patients with high ED use include transportation assistance, intensive case management, and SCD education.
However, this is an implementation effort, not a controlled evaluation. The utilization rankings rely on 2013–2019 data, referral thresholds are consensus-based and unvalidated, and detailed intervention processes remain under development.
The toolbox and coordination protocol are implementation strategies, not new national clinical standards. Their effects on treatment timeliness, referrals, admissions, and ED utilization still need to be evaluated.
💭 Discussion
How can statewide partnerships help emergency departments implement consistent sickle cell care?
What evidence is needed to determine whether coordinated support for patients with high ED use improves care and reduces utilization?
Share your perspective — your insights can help advance approaches to emergency care and coordination for people with sickle cell disease.
Source: Journal of Sickle Cell Disease, Volume 3, Issue 1, 2026 — Paula Tanabe; Mariam Kayle; Justin Calhoun; Beng Fuh; Olu Jegede; Jane Little; Elazzoa McArthur, Sr.; Todd L Savitt; Lauren Siewny; John J Strouse; Matthew Young; Payal Desai
#SickleCellDisease #SCDResearch #PatientCare #SickleCellCare #JournalOfSickleCellDisease #EmergencyCare #CareCoordination
Stay informed with the latest healthcare and research updates. Subscribe to our weekly newsletter:
40
Becoming a father was something Scott always hoped for, and starting a family gave him something meaningful to work toward.
Living with sickle cell disease meant that journey came with extra considerations for his health.
Scott spoke with his hematologist, made changes to his lifestyle, and navigated difficult moments while continuing to move toward the future he wanted.
For him, fatherhood became more than a milestone. It became a reminder that living with sickle cell disease does not mean letting go of the life you hope to build.
Every Warrior’s journey looks different, but Scott’s story shows that goals, family, and hope can still be part of the picture.
Want more Warrior stories, resources, and updates created for the sickle cell community?
Subscribe to the FSCDR Warrior Newsletter through the link in our bio.
#SickleCellDisease #SickleCellWarrior #Fatherhood #SickleCellCommunity #WarriorsWithinPodcast #FSCDR
34
Life is made up of moments like these.
The laughter. The milestones. The time spent with the people who matter most.
For Sickle Cell Warriors and their families, your support helps strengthen the care, research, education, and community that can make more of those moments possible.
Through 15 Sickle Cell Centers of Excellence, your generosity helps support specialized care across Florida.
Your support makes a difference.
Visit the link in our bio to give today.
#SickleCellDisease #SickleCellWarrior #SickleCellCommunity #GivingSeason #FSCDR
36
📚 SCD Weekly Practice Update
Blind Spots: Patient Knowledge and Practices around Ocular Complications in Sickle Cell Disease
A survey published in the Journal of Sickle Cell Disease assessed adults’ knowledge of ocular complications associated with sickle cell disease and their reported eye-care practices.
🔍 Study Highlights
Researchers surveyed 64 adults with SCD attending routine outpatient visits at the University of Illinois Health Adult Sickle Cell Center.
💡 Key findings included:
Overall knowledge was limited, with a mean score of 2.7 out of 7.
Although 61% recognized that SCD can affect vision, only 41% recognized that SCD can cause blindness, and 25% knew SCD-related blindness is not curable.
Among participants, 28% identified the emergency department as the first point of care for sudden vision problems, and 33% for new-onset floaters.
While 55% reported annual ophthalmology visits, 58% believed refraction testing for glasses constituted a full eye examination. Only 14% recognized that refraction alone was inadequate.
💡 Why It Matters
The findings identify a gap between reported eye-care engagement and understanding of the examinations needed to detect SCD-related retinal disease.
Patients may attend appointments for corrective lenses without realizing that refraction alone does not assess the retina for sickle cell retinopathy.
This was a single-site survey of 64 adults and relied on self-reported practices. The study did not verify screening records, examination findings, or clinical outcomes.
The study does not establish a new clinical guideline but highlights opportunities to reinforce retinal screening and clarify when sudden visual symptoms require urgent evaluation.
💭 Discussion
How can healthcare teams better explain the difference between routine vision testing and retinal screening for sickle cell retinopathy?
What approaches could improve understanding of when sudden visual symptoms require urgent evaluation?
Share your perspective — your insights can help strengthen eye-care education and screening awareness in sickle cell disease.
Source: Journal of Sickle Cell Disease, Volume 3, Issue 1, 2026 — Raine Solarin, BS; Aron Sebhat, MD; Robert Molokie, MD; Jennifer I Lim, MD
#SickleCellDisease #SCDResearch #PatientCare #SickleCellCare #JournalOfSickleCellDisease #SickleCellRetinopathy #EyeHealth
Stay informed with the latest healthcare and research updates. Subscribe to our weekly newsletter:
60
The FSCDR Symposium brings together Sickle Cell Warriors, researchers, healthcare professionals, caregivers, families, and community leaders to learn, connect, and exchange perspectives across the sickle cell community.
Join us June 10–13, 2027, in Fort Lauderdale, Florida, for the 21st Annual Sickle Cell Disease Research and Educational Symposium & the 50th National Sickle Cell Disease Scientific Meeting.
Register before February 18, 2027, and save $50 on registration. Sickle Cell Warriors and caregivers can register for free.
Be part of the conversations. Build new connections. Experience the community in person.
Early registration ends February 18, 2027.
Register and learn more at fscdr.org.
#SickleCellDisease #SickleCellWarrior #SickleCellCommunity #SickleCellResearch #FSCDRSymposium
1
40
"Sometimes we need hope as much as food, oxygen." ❤️ — Alex "A-Rod" Rodriguez
At the 20th Annual Sickle Cell Disease Research and Educational Symposium & 49th National Sickle Cell Disease Scientific Meeting, Alex "A-Rod" Rodriguez shared The Power of Hope.
Hope can change a life.
Mentors can change a future.
One person who believes in you can make all the difference.
His message celebrated the strength of Sickle Cell Warriors and everyone working to build a brighter future.
Watch The Power of Hope.
#FSCDR #AlexRodriguez #ThePowerOfHope #SickleCellDisease #Hope #Resilience #Inspiration
1
9
147
Medicare and Medicaid may sound similar, but they are two different health insurance programs.
Understanding the difference can help Sickle Cell Warriors and their families make more informed decisions about their healthcare coverage.
Medicare is a federal health insurance program for adults ages 65 and older and people with certain disabilities, regardless of income.
Medicaid is a joint federal and state health insurance program based on income and other eligibility requirements.
Knowing which program you may qualify for is the first step. From there, consider your healthcare needs, how often you visit the doctor, and what you can afford when exploring your coverage options.
Save this post for future reference, and share it with someone who may find it helpful.
#SickleCellDisease #SickleCellWarrior #Medicare #Medicaid #HealthInsurance #SickleCellCare #PatientEducation
1
105
📚 SCD Weekly Practice Update
Treating pain in SCD: design of a randomized crossover controlled Mediterranean diet feeding study
A study-design article published in the Journal of Sickle Cell Disease outlines a randomized crossover feeding study examining whether a Mediterranean diet may affect chronic non-vaso-occlusive pain, gut microbiome composition, and microbial metabolites in adults with sickle cell disease.
🔍 Study Highlights
Researchers plan to recruit 30 adults with SCD and chronic pain, with 24 expected to complete the trial. Participants will receive 28 days of a Mediterranean diet and 28 days of their habitual diet, separated by a 28-day washout period.
💡 Key findings included:
This is a study-design article, so no clinical outcome results are reported.
The primary outcome is patient-reported pain using PROMIS and ASCQ-Me measures.
Secondary outcomes include gut microbiome composition, metabolites, inflammatory markers, and body composition.
The trial will examine short-chain fatty acids and bile acids as part of its metabolomic analyses.
The study is registered as NCT06886477.
💡 Why It Matters
The protocol examines whether a structured dietary intervention may influence chronic pain and biological measures related to the gut–brain axis.
Its controlled feeding design and within-participant comparison may help generate preliminary evidence about a potential nonpharmacologic research direction.
However, the proposed relationships between diet, microbiome activity, and pain remain hypotheses. The study does not establish that a Mediterranean diet reduces SCD-related pain.
The planned sample is small, from one clinical center, and the 28-day diet periods cannot determine long-term effectiveness or sustainability. This is a research protocol and does not establish a new recommendation or change SCD pain-management guidelines.
💭 Discussion
What evidence would be needed to determine whether dietary interventions can meaningfully affect chronic pain in sickle cell disease?
How should future studies evaluate the relationship between diet, microbiome activity, and patient-reported pain?
Share your perspective — your insights can help advance research into supportive approaches for chronic pain in sickle cell disease.
Source: Journal of Sickle Cell Disease, Volume 3, Issue 1, 2026 — Josh Pekler, BA; Alyshia Hamm, MPH, RD; Juanita E Darby, PhD; Ivy Akpotu, MSN, RN; Rashi Rana, MS; Saba Nadeem, MS, RD; Nicollette Kessee, BS, RD; Adriana Garcia, BS; Tanner Wilson, MS; Alana Steffen, PhD; Beatriz Peñalver Bernabé, MS, PhD; Waddah Alrefai, MD; Z Jim Wang, PhD; Ardith Doorenbos, PhD, RN; Robert Molokie, MD; Lisa Tussing-Humphreys, PhD, MS, RD
#SickleCellDisease #SCDResearch #PatientCare #SickleCellCare #JournalOfSickleCellDisease #ChronicPain #NutritionResearch #MediterraneanDiet #GutMicrobiome
Stay informed with the latest healthcare and research updates. Subscribe to our weekly newsletter in comments below.
📚 SCD Weekly Practice Update
Trajectories of emergency department use among adolescents and young adults with sickle cell disease in North Carolina
A retrospective observational study published in the Journal of Sickle Cell Disease examined age-related patterns of emergency department (ED) use among adolescents and young adults with sickle cell disease in North Carolina.
🔍 Study Highlights
Researchers analyzed 3,614 individuals ages 14–30 using North Carolina Hospital Discharge Data from 2014–2019, representing 39,585 ED visits.
💡 Key findings included:
Three ED-use trajectories were identified: low use (95.2%), medium use (4.1%), and high use (0.7%).
Mean annual ED visits were 2.29 in the low-use group, 20.38 in the medium-use group, and 47.71 in the high-use group.
Utilization patterns were similar at age 14 but diverged after age 18.
Mean ED visits increased from 1.23 at age 14 to 5.35 at age 24, then declined to 4.64 by age 30.
Race was the only sociodemographic factor significantly associated with trajectory class, although the non-Black subgroup was small.
💡 Why It Matters
Higher-use groups also visited more distinct ED facilities annually, a pattern that may warrant further evaluation of care continuity and coordination.
The findings identify differences in utilization but do not establish why they occurred or show that a particular intervention would reduce ED use.
The study used 2014–2019 data and could not assess genotype, disease-modifying therapies, chronic opioid use, formal transition-program participation, or individual circumstances.
This study does not establish a new clinical recommendation or mandate changes in ED protocols. Its findings may prompt further evaluation of follow-up into young adulthood, coordination between pediatric and adult services, and repeated ED use across facilities.
💭 Discussion
How can healthcare teams better understand why ED use diverges after age 18 among young people with sickle cell disease?
What additional research is needed to improve care continuity and coordination during the transition to adult care?
Share your perspective — your insights can help advance approaches to transition care and emergency department utilization in sickle cell disease.
Source: Journal of Sickle Cell Disease, Volume 3, Issue 1, 2026 — Samuel R Wilson, MD, MSCR; Olu Jegede, MD, MHA; Sarah Leonard, MD, MPH; Tyra C Girdwood, PhD, RN; Wei Pan, PhD; Daniel Hatch, PhD; Camila Reyes, MS; Payal Desai, MD; Jane A Little, MD; Mariam Kayle, PhD
To stay informed with the latest healthcare and research updates. Subscribe to our weekly newsletter:
fscdr.org/healthcare/
#SickleCellDisease #SCDResearch #PatientCare #SickleCellCare #JournalOfSickleCellDisease #TransitionOfCare
1
68
Marriage can look different when sickle cell disease is part of the relationship.
For many Sickle Cell Warriors, support from a partner can mean having someone who recognizes when something is wrong, understands when plans have to change, and stays present through unexpected hospital visits or difficult days.
Having someone who understands the realities of sickle cell disease can make the journey feel less isolating especially when it takes a unexpected turn.
Watch more Sickle Cell Warrior stories on YouTube @FSCDR.
#SickleCellDisease #SickleCellWarrior #SickleCellCommunity #Marriage #CaregiverSupport #WarriorsWithinPodcast #FSCDR
3
46
📚 SCD Weekly Practice Update
Beyond the blood disorder: unlocking the individual and community factors that build resilience in adults with sickle cell
A secondary analysis published in the Journal of Sickle Cell Disease examined individual and community factors associated with resilience among adults with sickle cell disease.
🔍 Study Highlights
Researchers analyzed data from 276 adults with SCD recruited at two U.S. sites. Participants had a mean age of 39.67 years, and 73.3% reported annual household income below $60,000.
💡 Key findings included:
Higher physical function, positive provider communication, healthcare satisfaction, congregational support, and higher household income were associated with higher resilience.
Greater perceived illness threat, relationship stress, and neighborhood stress were associated with lower resilience.
Perceived illness threat showed the largest reported association with resilience among continuous predictors.
Participants reporting household income of $90,000 or more had higher resilience than those reporting $29,000 or less after controlling for neighborhood stress.
💡 Why It Matters
The findings suggest that resilience among adults with SCD is associated with factors extending beyond individual coping, including physical function, perceived illness threat, healthcare relationships, support systems, and economic and neighborhood circumstances.
However, this was a cross-sectional secondary analysis using convenience sampling at two U.S. sites. The study does not establish causality or determine whether resilience predicts later clinical outcomes such as hospitalization, vaso-occlusive crises, organ complications, survival, or quality of life.
Current ASH guidance supports routine screening for depression and anxiety and interdisciplinary, patient-centered pain care but does not establish resilience as a clinical treatment target. NHLBI guidance also includes assessment of social circumstances, psychological support, preventive care, and patient education.
💭 Discussion
How can healthcare teams better understand the factors associated with resilience among adults living with sickle cell disease?
What additional research is needed to determine whether resilience is associated with long-term clinical outcomes and quality of life?
Share your perspective — your insights can help advance patient-centered approaches to comprehensive sickle cell care.
Source: Journal of Sickle Cell Disease, Volume 3, Issue 1, 2026 — Danielle Ongondo, PhD, RN; Sharon Bryant, PhD; Serdar Atav, PhD; Rosemary Collier, PhD, RN
To stay informed with the latest healthcare and research updates. Subscribe to our weekly newsletter:
fscdr.org/healthcare/
#SickleCellDisease #SCDResearch #PatientCare #SickleCellCare #JournalOfSickleCellDisease #WholePersonCare #HealthcareCommunication
1
51
Did you know Sickle Cell Disease can affect your eyes, too?
Changes in the retina can develop without pain or obvious warning signs. That is why yearly eye exams can be an important part of ongoing sickle cell care.
FSCDR’s Monthly Eye Care Clinic gives Sickle Cell Warriors access to eye care at the FSCDR Sickle Cell Center of Excellence in Hollywood, Florida.
This month’s clinic:
1685 South State Road 7, Unit 4, Hollywood, FL 33023
October 21st, 2026
9AM–3 PM
Held every third Wednesday.
Save this date, and share it with a fellow Warrior or caregiver who may need the reminder.
#FSCDR #SickleCellDisease #SickleCellWarriors #SickleCellCare #EyeCare
4
84
"You are meant to live full lives." — Ryan Clark
At the 20th Annual Sickle Cell Disease Research and Educational Symposium & 49th National Sickle Cell Disease Scientific Meeting, Warrior Keynote Speaker Ryan Clark brought Hope in Action with a powerful reminder:
Your diagnosis does not define your future.
Your dreams matter.
Your life matters.
His message inspired Sickle Cell Warriors, caregivers, healthcare professionals, researchers, and community partners across the Symposium.
Watch the Warrior Keynote Hope in Action.
#FSCDR #RyanClark #HopeInAction #SickleCellDisease #Hope #Warriors #Inspiration
1
44
Have a story, perspective, or experience with sickle cell disease you would like to share?
FSCDR is opening a limited number of guest opportunities for the Warriors Within Podcast.
We are looking to hear from:
Sickle Cell Warriors, Caregivers, and Healthcare professionals working in sickle cell disease.
Community members from across the country are welcome to express interest.
This is an opportunity to share your experiences, lessons, perspectives on care, and hopes for the sickle cell community.
Interested in joining the conversation?
Complete the Podcast Guest Interest Form:
forms.gle/LdxNJazcENz2z1TW6
#SickleCellDisease #SickleCellWarrior #SickleCellCommunity #WarriorsWithinPodcast #FSCDR
3
55
📚 SCD Weekly Practice Update
Community leads the way: the essential role of CBO-anchored community health worker partnerships in strengthening hydroxyurea uptake and sickle cell disease care
A mixed-methods evaluation published in the Journal of Sickle Cell Disease examined a citywide initiative designed to increase hydroxyurea use among children with sickle cell disease, with a focus on community-based organization (CBO) and community health worker (CHW) partnerships.
🔍 Study Highlights
The initiative was implemented across NYC Health + Hospitals from 2022–2023 and impacted approximately 400 pediatric patients annually. A matched cohort of 730 Medicaid-enrolled patients ages 9 months–21 years was included in the formal evaluation.
💡 Key findings included:
Hydroxyurea fills increased from 57.1% at baseline to 79.1% during the intervention.
Adherence, defined as more than 80% of days covered, increased from 32.5% to 40.0%.
Patients seen by participating providers had 14% higher hydroxyurea-fill rates and were 10% more likely to meet the adherence threshold.
These patients also had an 8% lower likelihood of an emergency department visit after adjustment.
Qualitative findings identified CBO–CHW partnerships as important for education, navigation, trust-building, and practical support.
💡 Why It Matters
Hydroxyurea is an evidence-based disease-modifying therapy for sickle cell disease, but uptake and adherence remain suboptimal.
This evaluation suggests that CBOs and CHWs may complement provider education and system-level tools by helping families understand hydroxyurea, address concerns, navigate pharmacies and insurance, coordinate transportation, and remain engaged with care.
However, provider education, electronic health-record tools, financial incentives, and CBO–CHW support were implemented together. The study therefore cannot determine the independent effect of the CBO–CHW partnership.
Current guidance supports hydroxyurea use for eligible patients and shared decision-making but does not establish a specific CBO–CHW model for improving uptake or adherence.
💭 Discussion
Which components of CBO–CHW partnerships are most important for improving hydroxyurea uptake and adherence?
How can pediatric sickle cell programs determine whether improvements are sustained over time and across different healthcare settings?
Share your perspective — your insights can help strengthen approaches to hydroxyurea education, access, and long-term engagement in sickle cell care.
Source: Journal of Sickle Cell Disease, Volume 3, Issue 1, 2026 — Candice Deler, MSW; Salma Muhyedeen, CHW; Toni Denicola, NP; Candace Alphonso, MPH; Urvi Patel, MPH; Bruce Bernstein; Marcy Stein-Albert, MD; Jean-Bernard Poulard, MD, MBA; Kenneth Rivlin, MD, PhD
#SickleCellDisease #SCDResearch #PatientCare #SickleCellCare #JournalOfSickleCellDisease #Hydroxyurea #CommunityHealthWorkers
61
Cold weather can mean something very different for a Sickle Cell Warrior.
Winter could mean staying inside more often, missing time outdoors, and weighing everyday activities against the possibility of severe pain and other complications.
So when someone living with sickle cell disease needs to change plans, stay home, or adjust their schedule during colder months, lead with patience and understanding. What may feel like a simple cold day to one person can carry a much heavier impact for someone else.
As a reminder give Warriors grace. Some of the hardest parts of sickle cell disease are the ones you may never see.
#SickleCellDisease #SickleCellWarrior #SickleCellAwareness #SickleCellCare #ChronicIllness #FSCDR
3
62
For Denise Rainford, one message stands out for Sickle Cell Warriors: find a community.
Living with sickle cell disease can involve mental, emotional, and financial challenges in addition to physical health. Denise highlights the importance of having people and organizations to turn to for support.
She points to community organizations like Shak’s Hope as an example of how connection, understanding, and shared experience can give Warriors added strength.
Watch more Sickle Cell Warrior stories by visiting our YouTube @FSCDR.
#SickleCellDisease #SickleCellWarrior #SickleCellCommunity #PatientSupport #SickleCellAwareness #FSCDR
Looking to better understand your Medicare options for 2027?
Join us for a Medicare 2027 Plan Review Event with licensed independent insurance agent Latoya Ward.
Attendees can review provider networks, plan benefits, prescription coverage, and available plan options based on their individual needs.
Monday, October 12, 2026
1:00 PM–3:00 PM
FSCDR
1685 S State Road 7, Unit 4
Hollywood, FL 33023
1
52
📚 SCD Weekly Practice Update
Pulmonary function among children and young adults with sickle cell disease: the potential role of air pollution
A retrospective study published in the Journal of Sickle Cell Disease examined whether higher ambient air-pollution concentrations were associated with abnormal pulmonary function in children and young adults with sickle cell disease.
🔍 Study Highlights
Researchers analyzed 10 years of data from 65 participants ages 5–19 in Jefferson County, Alabama. Most had HbSS, 84.6% had asthma, and 81.5% were receiving SCD-modifying therapy.
💡 Key findings included:
Higher monthly average nitrogen dioxide (NO₂) concentrations were associated with abnormal forced expiratory volume in 1 second (FEV₁).
In unadjusted analyses, each 1 ppb increase in monthly average NO₂ was associated with 53% higher odds of abnormal FEV₁.
The adjusted association was not statistically significant.
FEV₁ and forced vital capacity were frequently reduced, while obstruction indices were normal in all participants.
💡 Why It Matters
Pulmonary complications are an important source of morbidity in SCD. This study provides preliminary evidence that higher monthly average NO₂ concentrations may be associated with abnormal FEV₁ in children and young adults with SCD.
The study was small, observational, and limited to a single county. Researchers could not adjust for several potential confounders, including smoking or vaping, secondhand smoke, home conditions, socioeconomic factors, and meteorological conditions. The findings show an association, not causation.
No SCD-specific guideline establishes an ambient NO₂ exposure threshold or recommends routine air-pollution monitoring as part of SCD management. These findings support further research rather than a change in clinical practice.
💭 Discussion
What additional evidence is needed to clarify the relationship between air pollution and pulmonary function in sickle cell disease?
How should future studies evaluate whether reducing air-pollution exposure improves pulmonary outcomes?
Share your perspective — your insights can help advance research into environmental factors that may affect pulmonary health in sickle cell disease.
Source: Journal of Sickle Cell Disease, Volume 3, Issue 1, 2026 — Kelsey M Maclin, PhD, MS; Charity J Morgan, PhD; Ruzmyn Vilcassim, PhD, MS; Azar Abadi, PhD; Ammar Alishlash, MD; Brandi M Pernell, DNP, MSPH
#SickleCellDisease #SCDResearch #PatientCare #SickleCellCare #JournalOfSickleCellDisease #PulmonaryHealth




























